The term malignant neoplasm refers to a cancerous growth or tumor characterized by uncontrolled, abnormal cellular proliferation. Unlike benign tumors, malignant neoplasms have the aggressive ability to invade and destroy adjacent normal tissues and can spread (metastasize) to distant organs via the lymphatic system or bloodstream. Major histological categories include carcinomas (arising from epithelial tissue), sarcomas (arising from connective or mesenchymal tissue), leukemias (affecting blood-forming tissue), and lymphomas (affecting the immune system).
The combined phrase translates essentially to a “wicked new formation.” Historically, the aggressive, destructive nature of these growths led ancient and medieval physicians to describe them with terms denoting malice or evil behavior, distinguishing them from harmless (“benign”) swellings.
🔀 ALIASES / ALTERNATE TERMS
Cancer
Malignancy
Malignant tumor
CA(common clinical abbreviation)
Primary malignancy(the original site of the tumor)
Secondary malignancy(a site of metastasis)
🔗 RELATED TERMS
Metastasis — the spread of cancer cells from the primary site to other parts of the body
Carcinoma — a malignant neoplasm of epithelial origin (e.g., skin, lung, breast, prostate)
Sarcoma — a malignant neoplasm of mesenchymal/connective tissue (e.g., bone, cartilage, muscle)
Benign neoplasm — a non-cancerous tumor that remains localized and does not invade or metastasize
Oncology — the branch of medicine focused on diagnosing, treating, and researching cancer
chemotherapy — the systemic use of chemical agents to destroy or slow the growth of cancer cells
Carcinoma in situ (CIS) — early-stage cancer that is confined to the layer of cells where it began and has not invaded surrounding tissue
⚠️ Coding Note: In ICD-10-CM, coding for a malignant neoplasm strictly requires utilizing the Table of Neoplasms to determine if the site is Primary or Secondary (metastatic). If a patient is presenting solely for the administration of chemotherapy, radiation, or immunotherapy, the Z-code for the therapy (e.g., Z51.11) must be listed as the principal/first-listed diagnosis, followed immediately by the active malignant neoplasm code. If the cancer has been completely excised or eradicated and there is no longer active treatment directed at it, you must use a “Personal history of” (Z85.- category) code instead of the active active malignancy C-code.